TSX: MFI
www.mapleleaffoods.com
Maple Leaf records year-over-year Adjusted
EBITDA growth of 55% to $116
million
2024 Outlook remains unchanged, with the Company
on track to meet its 2024 priorities
MISSISSAUGA, ON, May 2, 2024
/PRNewswire/ - Maple Leaf Foods Inc. ("Maple Leaf Foods" or "the
Company") (TSX: MFI) today reported its financial results
for the first quarter ended March 31,
2024.
"In the first quarter of 2024, we delivered Adjusted EBITDA of
$116 million, 55% higher than the
same period last year," said Curtis
Frank, President and Chief Executive Officer of Maple Leaf
Foods. "With sales growth within our prepared meats portfolio, and
a sequential improvement in our meat protein Adjusted EBITDA margin
to 10.8%, and a 310 basis point improvement over last year, we took
a meaningful step forward toward delivering our full business
potential.
"The modest decline we saw in overall sales compared to Q1 2023
was primarily a function of sourcing decisions to reduce outside
purchases in poultry and pork, impacting sales in the short term
while setting us up to deliver on our plans moving forward.
"Looking ahead, we expect the momentum in our business to
continue to accelerate. Pork headwinds, while still a challenge,
are easing, and our attention is squarely on executing our
refreshed Strategic Blueprint," continued Frank. "With a
powerful platform of brands, a network of world-class assets and
our leadership in sustainability, we have the right strategy and
team in place to drive growth in Canada, accelerate our reach in the U.S. and
fully realize the benefits of our recent capital investments."
First Quarter 2024 Highlights
- Adjusted Earnings Before Interest, Taxes, Depreciation and
Amortization ("EBITDA")(i) grew to $116.4 million, a 55% increase from the first
quarter of last year, with Adjusted EBITDA margin increasing from
6.4% to 10.1% for the same period.
- Net earnings for the first quarter of 2024 were $51.6 million ($0.42 per basic share) compared to a loss of
$57.7 million ($0.48 loss per basic share) last year.
- Start up expenses(i) related to Capital
Construction(i) projects, decreased by
approximately 67% to $11.4 million in
the current quarter compared to last year.
- Sales in the Prepared Foods operating unit decreased
approximately 0.4%, with prepared meats increasing 2.9% offset by
declines in plant protein and poultry of 5.7% and 7.1%
respectively, compared to last year. Sales in the Pork operating
unit decreased by 4.5% compared to last year.
- Free cash flow(i) improved to $73.6 million from $12.4
million in the same quarter last year.
Outlook
- For the full year 2024, the Company expects:
- Low-to-mid single-digit revenue growth
- Adjusted EBITDA margin expansion over 2023
- To generate strong free cash flow and delever the balance
sheet
- To reflect the refreshed Blueprint and realignment of its
organizational structure, as of the first quarter of 2024, the
Company is reporting its business and operational results as a
consolidated protein company, to align with how management monitors
and measures business performance. With these changes, the Company
believes it is positioned to achieve a consolidated Adjusted EBITDA
margin target of 14-16%, in normal market conditions.
(i)
|
Refer to the section
titled Non-IFRS Financial Measures in this news release.
|
Financial Highlights
Measure(i)
|
Three months ended March 31,
|
(Unaudited)
|
2024
|
2023
|
Change
|
Sales(ii)
|
$
1,153.2
|
$
1,171.1
|
(1.5) %
|
Net Earnings
(Loss)
|
$
51.6
|
$
(57.7)
|
189.3 %
|
Basic Earnings (Loss)
per Share
|
$
0.42
|
$
(0.48)
|
187.5 %
|
Adjusted Operating
Earnings(iii)
|
$
53.0
|
$
19.3
|
174.4 %
|
Adjusted Earnings
(Loss) per Share(iii)
|
$
0.04
|
$
(0.12)
|
133.3 %
|
Adjusted
EBITDA(iii)
|
$
116.4
|
$
75.3
|
54.6 %
|
Free Cash
Flow(iii)
|
$
73.6
|
$
12.4
|
493.5 %
|
Net
Debt(iii)
|
$
(1,722.8)
|
$
(1,677.3)
|
2.7 %
|
Adjusted
EBT(iii)
|
$
10.4
|
$
(14.0)
|
174.3 %
|
(i)
|
All financial
measures in millions of dollars except Basic and Adjusted Earnings
per Share.
|
(ii)
|
Quarterly amounts
for 2023 have been adjusted to eliminate new sales agreements
entered into during the year that contained an expectation of
repurchase, which had previously been reported as external
sales.
|
(iii)
|
Refer to the section
titled Non-IFRS Financial Measures in this news
release.
|
Sales for the first quarter of 2024 were $1,153.2 million compared to $1,171.1 million last year, a decrease of 1.5%,
Sales in the Prepared Foods operating unit decreased approximately
0.4%, with prepared meats increasing 2.9% offset by declines in
plant protein and poultry of 5.7% and 7.1% respectively, compared
to last year. Sales in the Pork operating unit decreased by 4.5%
compared to last year.
Net earnings for the first quarter of 2024 were $51.6 million ($0.42 per basic share) compared to a loss of
$57.7 million ($0.48 loss per basic share) last year. Net
earnings were positively impacted by reduced feed costs, operating
efficiencies, lower start-up expenses, reduced restructuring costs,
and a positive impact of unrealized mark to market valuation on
biological assets. Results were negatively impacted by higher
interest expense due to increased interest rates and higher debt,
as well as increased tax expenses.
Adjusted Operating Earnings for the first quarter of 2024 were
$53.0 million compared to
$19.3 million last year, and Adjusted
Earnings per Share for the first quarter of 2024 was $0.04 compared to loss of $0.12 last year.
Adjusted Earnings Before Taxes
("Adjusted EBT") for the first quarter of 2024 were $10.4 million
compared to loss of $14.0 million last
year.
For further discussion on key operational metrics and results
refer to the section titled
Operating Review.
Note: Several items
are excluded from the discussions of underlying earnings
performance as they are not representative of ongoing operational
activities. Refer to the section entitled Non-IFRS Financial
Measures at the end of this news release for a description and
reconciliation of all non- IFRS financial measures.
|
Operating Review
Earlier this year, the Company announced an update to its
strategic blueprint ("Blueprint") that reflects the progress it has
made toward achieving its Purpose and Vision and establishes the
roadmap for the next chapter for how Maple Leaf Foods intends to
deliver on these objectives.
To execute on this Blueprint, the Company has combined its Meat
and Plant Protein businesses and aligned its organizational
structure to focus on its growth potential in key markets, drive
operational efficiencies, and provide clear accountability for
strategic execution. Based on this realignment and focus as a
protein company, as of the first quarter of 2024, Maple Leaf Foods
is reporting its business and operational results as a consolidated
protein company, to align with how management monitors and measures
business performance. With these changes, the Company believes it
is positioned to achieve a consolidated Adjusted EBITDA margin
target of 14% to 16% in normal market conditions. Previously,
the Company's Adjusted EBITDA margin target of 14% to 16% in normal
market conditions was solely for meat protein. The Company achieved
an Adjusted EBITDA margin for meat protein of 10.8% in the first
quarter of 2024.
As a consolidated protein company, Maple Leaf Foods has two
operating units: Prepared Foods and Pork, which represent on
average approximately 75% and 25% of total Company revenue
respectively. Prepared Foods combines the operations of prepared
meats, plant protein, and poultry, which represent on average
approximately 50%, 5% and 20% of total Company revenue
respectively.
The following table summarizes the Company's sales, gross
profit, SG&A, Adjusted Operating Earnings, Adjusted EBITDA,
Adjusted EBITDA Margin, and Adjusted EBT for the three months
ended March 31, 2024 and March 31, 2023.
|
Three months ended
March 31,
|
($ millions)
(Unaudited)
|
2024
|
2023
|
Sales(i)
|
$
1,153.2
|
$
1,171.1
|
Gross profit
(loss)
|
$
226.3
|
$
76.4
|
Selling, general and
administrative expenses
|
$
110.0
|
$
102.7
|
Adjusted Operating Earnings(ii)
|
$
53.0
|
$
19.3
|
Adjusted EBITDA(ii)
|
$
116.4
|
$
75.3
|
Adjusted EBITDA
Margin(ii)
|
10.1 %
|
6.4 %
|
Adjusted EBT(i)
|
$
10.4
|
$
(14.0)
|
(i)
|
Quarterly amounts
for 2023 have been adjusted to eliminate new sales agreements
entered into during the year that contained an expectation of
repurchase, which had previously been reported as external
sales.
|
(ii)
|
Refer to the section titled Non-IFRS Financial
Measures in this news release.
|
Sales for the first quarter decreased 1.5% to $1,153.2 million compared to $1,171.1 million last year. Sales in the Prepared
Foods operating unit decreased approximately 0.4%, with prepared
meats increasing 2.9% offset by declines in plant protein and
poultry of 5.7% and 7.1% respectively, compared to last year. Sales
in the Pork operating unit decreased by 4.5% compared to last year.
Volume and mix drove the increase in sales in prepared meats, while
decreases in volume in fresh poultry were driven by reduced sales
to industrial channels; and in Pork by a reduction in hog purchases
for processing and a negative foreign exchange impact.
Gross profit for the first quarter increased to $226.3 million (gross margin of 19.6%) compared
to $76.4 million (gross margin of
6.5%) last year. The improvement in gross profit was driven by
improving pork market conditions, operating efficiencies at the
London Poultry plant, and a higher unrealized mark to market
valuation adjustment on biological assets, due to changes in hog
and feed markets. In addition, gross profit benefited from reduced
start-up expenses related to Capital Construction projects, which
decreased by approximately 67% in the current quarter compared to
last year.
SG&A expenses for the first quarter were $110.0 million compared to $102.7 million last year. The increase in
SG&A expenses was primarily driven by higher variable
compensation.
Adjusted Operating Earnings for the first quarter were
$53.0 million compared to
$19.3 million last year, driven
primarily by the drivers noted above for gross profit and SG&A,
and excluding the impacts of unrealized mark to market valuation
adjustments and start-up expenses, which are excluded in the
calculation of Adjusted Operating Earnings.
Adjusted EBITDA for the first quarter were $116.4 million compared to $75.3 million last year, driven by factors
consistent with those noted above and also excluding the impact of
unrealized mark to market valuation adjustments and start-up
expenses. Adjusted EBITDA Margin for 2024 was 10.1% compared to
6.4% last year, also driven by factors consistent with those noted
above.
Adjusted EBT for the first quarter were $10.4 million compared to a loss of $14.0 million last year, driven by factors
consistent with those noted above, as well as a $10.5 million increase in interest expense as a
result of increased interest rates and higher debt related to
capital investments in recent years and also excluding the impacts
of unrealized mark to market valuation adjustments and start-up
expenses.
Other Matters
On May 1, 2024, the Board of
Directors approved a quarterly dividend of $0.22 per share (an increase of $0.01 per share from the 2023 first quarter
dividends), $0.88 per share on an
annual basis, payable June 28, 2024
to shareholders of record at the close of business June 6, 2024. Unless indicated otherwise by the
Company at or before the time the dividend is paid, the dividend
will be considered an eligible dividend for the purposes of the
"Enhanced Dividend Tax Credit System". The Board of Directors has
also approved the issuance of common shares from treasury at a two
percent discount under the Company's Dividend Reinvestment Plan
("DRIP"). Under the DRIP, investors holding the Company's common
shares can receive common shares instead of cash dividend payments.
Further details, including how to enroll in the program are
available at
https://www.mapleleaffoods.com/investors/stock-information.com.
Conference Call
A conference call will be held at 8:00 a.m. ET on May 2, 2024, to review Maple
Leaf Foods' first quarter financial results. To
participate in the call, please dial 416-764-8650 or
1-888-664-6383. For those unable to participate, playback will be
made available an hour after the event at 416-764-8677 or
1-888-390-0541 (Passcode: 900050#).
A webcast of the first quarter conference call will also be
available at: https://www.mapleleaffoods.com.
The Company's full consolidated interim financial statements
("Consolidated Interim Financial Statements") and related
Management's Discussion and Analysis are available on the Company's
website and on SEDAR+ at www.sedarplus.ca.
An investor
presentation related to the Company's
first quarter financial results is available
at www.mapleleaffoods.com and can be found under
Presentations and Webcasts on the Investors page.
Outlook
Maple Leaf Foods is a leading consumer protein company built on
a powerful portfolio of brands, with a leading voice in
sustainability and food security. The Company's strategic Blueprint
defines how it will advance its vision to be the most sustainable
protein company on earth while delivering on its commercial and
financial objectives.
The Company recognizes that macro-economic factors and global
conflict continue to define the current operating environment,
contributing to higher interest rates, inflation, supply chain
tensions, and pressures on agricultural, commodity and foreign
exchange markets. As a result, consumers and businesses alike are
adapting their behaviour which impacts demand and product mix. The
Company leverages its data-driven insights to stay close to these
dynamics, and it is confident in the resilience of its brands,
business model and strategy to manage through prevailing economic
conditions.
Earlier this year, Maple Leaf Foods refreshed its Blueprint and
announced it was realigning its organizational structure to support
its new strategic orientation as it brings together its Meat and
Plant Protein businesses under a single umbrella with a clear and
consistent focus on driving profitable growth in Canada, the U.S., and internationally
across its entire protein portfolio.
With this focus, the Company expects to achieve an overall
consolidated Adjusted EBITDA margin target of 14% to 16% in normal
market conditions. Prior to this quarter, this Adjusted EBITDA
margin target applied to the previous Meat Protein segment but now
applies on a consolidated protein basis.
For the full year 2024, the Company
expects:
- Low-to-mid single-digit revenue growth
- Adjusted EBITDA margin expansion from 2023, supported by the
benefits of:
- Profitable growth of its leading portfolio of protein
brands
- Returns from investments in the London Poultry Plant and the
Bacon Centre of Excellence
- Leadership in sustainable meats
- Driving operational and cost efficiencies
- To generate strong free cash flow and delever its balance sheet
by:
- Improving margins and overall profitability as outlined
above
- Generating the targeted returns on its capital investments at
the London Poultry Plant and the Bacon Centre of Excellence,
including reducing start-up expenses, maximizing efficiencies and
onboarding new customers
- Exercising disciplined capital management, with total capital
expenditures this year expected to be in the range of $170 - $190
million, largely focused on maintenance capital and
optimization of its existing network
Maple Leaf Foods will also continue to advance its ambitious
sustainability agenda, including leading the real food movement,
advancing its animal care initiatives, seeking solutions to address
food insecurity, accelerating its efforts to reduce its
environmental footprint and continuing to deliver safe food made in
a safe work environment.
Non-IFRS Financial Measures
The Company uses the following non-IFRS measures: Adjusted
Operating Earnings, Adjusted Earnings per Share, Adjusted EBITDA,
Adjusted EBITDA Margin, Adjusted EBT, Construction Capital,
Net Debt, Net Debt to trailing four quarters Adjusted EBITDA, Free
Cash Flow and Return on Net Assets. Management believes that
these non-IFRS measures provide useful information to
investors in measuring the financial performance of the Company for
the reasons outlined below. These measures do not have a
standardized meaning prescribed by IFRS and therefore they may
not be comparable to similarly titled measures presented by other
publicly traded companies and should not be construed as an
alternative to other financial measures determined in accordance
with IFRS.
Adjusted Operating Earnings, Adjusted EBITDA, Adjusted EBITDA
Margin and Adjusted EBT
Adjusted Operating Earnings, Adjusted EBITDA, Adjusted
EBITDA Margin and Adjusted EBT are non-IFRS measures used
by Management to evaluate financial operating results. Adjusted
Operating Earnings is defined as earnings before other income,
income taxes and interest expense adjusted for items that are not
considered representative of ongoing operational activities of the
business and certain items where the economic impact of the
transactions will be reflected in earnings in future periods when
the underlying or related asset is sold or transferred. Adjusted
EBITDA is defined as Adjusted Operating Earnings plus depreciation
and intangible asset amortization, adjusted for items included in
other expense that are considered representative of ongoing
operational activities of the business. Adjusted EBITDA Margin is
calculated as Adjusted EBITDA divided by sales. Adjusted
EBT is used annually by the Company to
evaluate its performance and is a component of calculating bonus
entitlements under the Company's short term incentive plan. It is
defined as Adjusted EBITDA plus interest income, less
depreciation and amortization, and interest expense.
The table below provides a reconciliation of earnings (loss)
before income taxes as reported under IFRS in the Consolidated
Interim Financial Statements to Adjusted Operating Earnings,
Adjusted EBITDA and Adjusted
EBT for the three months
ended March 31, 2024 as indicated below. Management
believes that these non-IFRS measures are useful in assessing the
performance of the Company's ongoing operations and its ability to
generate cash flows to fund its requirements, including the
Company's capital investment program.
|
Three months ended March 31,
|
($
millions)(i)
(Unaudited)
|
2024
|
2023
|
Earnings (loss) before income
taxes
|
$
73.8
|
$
(69.9)
|
Interest
expense and other financing costs
|
42.1
|
31.6
|
Other
expense
|
1.2
|
4.3
|
Restructuring and other related
(reversals) costs
|
(0.7)
|
7.7
|
Earnings (loss) from
operations
|
$
116.3
|
$
(26.3)
|
Start-up
expenses from Construction Capital(ii)
|
11.4
|
34.8
|
Change
in fair value of biological assets
|
(69.1)
|
1.1
|
Unrealized and deferred (gain) loss on derivative contracts
|
(5.6)
|
9.7
|
Adjusted Operating Earnings
|
$
53.0
|
$
19.3
|
Depreciation and
amortization
|
65.0
|
57.7
|
Items included in other income
(expense) representative of ongoing operations(iii)
|
(1.5)
|
(1.7)
|
Adjusted EBITDA
|
$
116.4
|
$
75.3
|
Adjusted EBITDA
Margin(iv)
|
10.1 %
|
6.4 %
|
Interest expense and other financing costs
|
(42.1)
|
(31.6)
|
Interest income
|
1.0
|
—
|
Depreciation and amortization
|
(65.0)
|
(57.7)
|
Adjusted EBT
|
$
10.4
|
$
(14.0)
|
(i)
|
Totals may not add
due to rounding.
|
(ii)
|
Start-up expenses
are temporary costs as a result of operating new facilities that
are or were previously classified as Construction Capital. These
costs can include training, product testing, yield and labour
efficiency variances, duplicative overheads and other temporary
expenses required to ramp-up production.
|
(iii)
|
Primarily includes
certain costs associated with sustainability projects, gains and
losses on the impairment and sale of long-term assets, legal
settlements, gains and losses on investments, and other
miscellaneous expenses.
|
(iv)
|
Quarterly amounts
for 2023 have been adjusted to eliminate new sales agreements
entered into during the year that contained an expectation of
repurchase, which had previously been reported as external
sales.
|
Adjusted Earnings per Share
Adjusted Earnings per Share, a non-IFRS measure, is used by
Management to evaluate financial operating results. It is defined
as basic earnings per share and is adjusted on the same basis
as Adjusted Operating Earnings. The table below provides
a reconciliation of basic earnings per share as reported under IFRS
in the Consolidated Interim Financial Statements to Adjusted
Earnings per Share for the three months ended March 31 as indicated below. Management believes
this basis is the most appropriate on which to evaluate financial
results as they are representative of the ongoing operations of the
Company.
($ per share)
|
Three months ended
March 31,
|
(Unaudited)
|
2024
|
2023
|
Basic earnings (loss)
per share
|
$
0.42
|
$
(0.48)
|
Restructuring and
other related costs(i)
|
0.00
|
0.06
|
Items included in
other expense not considered representative of ongoing
operations(ii)
|
0.00
|
0.02
|
Start-up expenses
from Construction Capital(iii)
|
0.07
|
0.21
|
Change in fair value
of biological assets
|
(0.42)
|
0.01
|
Change in unrealized
and deferred fair value on derivatives
|
(0.03)
|
0.06
|
Adjusted Earnings per Share
|
$
0.04
|
$
(0.12)
|
(i)
|
Includes per share impact
of restructuring and other related
costs, net of tax.
|
(ii)
|
Primarily includes
legal fees and settlements, gains or losses on investment property, and transaction related costs, net of tax.
|
(iii)
|
Start-up expenses are temporary costs as a result of operating new facilities that are or have been classified as Construction Capital.
These costs can include
training, product testing, yield and labour
efficiency variances, duplicative overheads and other temporary expenses
required to ramp- up production, net of
tax.
|
Construction Capital
Construction Capital, a non-IFRS measure, is used by Management
to evaluate the amount of capital resources invested in specific
strategic development projects that are not yet operational. It is
defined as investments and related financing charges in projects
over $50.0 million that are related
to longer-term strategic initiatives, with no returns expected for
at least 12 months from commencement of construction and the asset
is re-categorized from Construction Capital once operational. There
are no Construction Capital projects as at March 31, 2024 as all projects have been
completed and have been recategorized as regular property and
equipment. The following table is a summary of Construction
Capital activity and debt financing for the periods indicated
below.
|
|
|
($
thousands) (Unaudited)
|
2024
|
2023
|
Property and
equipment and intangibles at January 1
|
$
2,596,839
|
$
2,663,985
|
Other capital and
intangible assets at January 1(i)
|
2,596,839
|
2,654,419
|
Construction Capital at January 1
|
$
—
|
$
9,566
|
Additions
|
—
|
8,822
|
Construction Capital at March
31(ii)
|
$
—
|
$
18,388
|
Other
capital and intangible assets at March
31(i)
|
2,569,440
|
2,635,039
|
Property and equipment and intangibles at March 31
|
$
2,569,440
|
$
2,653,427
|
|
|
|
Construction Capital
debt financing(iii)(iv)
|
$
—
|
$
18,093
|
(i)
|
Other capital and intangible assets consists of
property and equipment and intangibles that do not meet the
definition of Construction Capital.
|
(ii)
|
As at March 31, 2024 the net book value of
Construction Capital includes $0.0 million related to intangible
assets (2023: $0.2 million).
|
(iii)
|
Does not include
$882.8 million in capital that has been transferred out but is
still in the start-up stage (2023: $1,008.0
million).
|
(iv)
|
Assumed to be fully funded by debt to the extent that
the Company has Net Debt outstanding. Construction Capital debt
financing excludes interest paid and
capitalized.
|
Net Debt
The following table reconciles Net Debt and Net Debt
to Adjusted EBITDA to amounts reported under IFRS in the
Company's
Consolidated Interim Financial Statements as at March 31 as indicated below. The Company
calculates Net Debt as cash and cash
equivalents, less long-term debt and bank indebtedness. Management
believes this measure is useful in assessing the amount of
financial leverage employed.
($ thousands)
|
As at March
31,
|
(Unaudited)
|
2024
|
2023
|
Cash and cash equivalents
|
$ 206,393
|
$
79,433
|
Current portion of
long-term debt
|
$
(401,538)
|
$
(1,130)
|
Long-term
debt
|
(1,527,665)
|
(1,755,560)
|
Total debt
|
$
(1,929,203)
|
$
(1,756,690)
|
Net Debt
|
$
(1,722,810)
|
$
(1,677,257)
|
Adjusted EBITDA
|
$ 116,446
|
$
75,296
|
Trailing four quarters Adjusted
EBITDA(i)
|
468,738
|
281,339
|
Net Debt to trailing four quarters Adjusted
EBITDA
|
3.7
|
6.0
|
(i)
|
Trailing four
quarters includes Q2 2023, Q3 2023, Q4 2023 and Q1 2024 for 2024;
and Q2 2022, Q3 2022, Q4 2022 and Q1 2023 for 2023.
|
Free Cash Flow
Free Cash Flow, a non-IFRS measure, is used by Management to
evaluate cash flow after investing in the maintenance of the
Company's asset base. It is defined as cash provided by operations,
less Maintenance Capital(i) and
associated interest paid and capitalized. The
following table calculates Free Cash Flow for the periods indicated
below:
($
thousands)
|
Three months ended March 31,
|
(Unaudited)
|
2024
|
2023
|
Cash provided by
operating activities
|
$
87,325
|
$
35,714
|
Maintenance
Capital(i)
|
(13,436)
|
(23,107)
|
Interest paid and
capitalized related to Maintenance Capital
|
(263)
|
(234)
|
Free Cash Flow
|
$
73,626
|
$
12,373
|
(i)
|
Maintenance Capital is defined as non-discretionary
investment required to maintain the Company's existing operations
and competitive position. For the three months ended March 31,
2024, total capital spending of $23.8 million (2023: $49.3 million)
shown on the Consolidated Statements of Cash Flows is made up of
Maintenance Capital of $13.4 million (2023: $23.1 million), and
Growth Capital of $10.4 million (2023: $26.2 million). Growth
Capital is defined as discretionary investment meant to create
stakeholder value through initiatives that for example, expand
margins, increase capacities or create further competitive
advantage..
|
Return on Net Assets ("RONA")
RONA is calculated by dividing tax effected earnings
from operations (adjusted for items which
are not considered representative of the
underlying operations of the business) by average monthly net
assets. Net assets are defined as total assets (excluding cash and
deferred tax assets) less non-interest bearing liabilities
(excluding deferred tax liabilities). Management believes that
RONA is an appropriate basis upon which to evaluate long-term
financial performance.
Forward-Looking Statements
This document contains, and the Company's oral and written
public communications often contain, "forward-looking information"
within the meaning of applicable securities law. These statements
are based on current expectations, estimates, projections,
beliefs, judgements and assumptions based on information
available at the time the applicable forward-looking statement was
made and in light of the Company's experience combined with its
perception of historical trends. Such statements include, but are
not limited to, statements with respect to objectives and goals, in
addition to statements with respect to beliefs, plans, targets,
goals, objectives, expectations, anticipations, estimates, and
intentions. Forward-looking statements are typically identified by
words such as "anticipate", "continue", "estimate", "expect",
"may", "will", "project", "should", "could", "would", "believe",
"plan", "intend", "design", "target", "undertake", "view",
"indicate", "maintain", "explore", "entail", "schedule",
"objective", "strategy", "likely", "potential", "outlook", "aim",
"propose", "goal", and similar expressions suggesting future events
or future performance. These statements are not guarantees of
future performance and involve assumptions, risks and uncertainties
that are difficult to predict.
By their
nature, forward-looking statements involve known and unknown risks,
uncertainties and other
factors that may cause
actual results or events to differ materially from those anticipated in such forward-looking statements. The Company
believes the expectations reflected in the forward-looking
statements are reasonable, but no assurance can be given that these
expectations will prove to be correct and such forward-looking
statements should not be unduly relied upon.
Specific forward-looking information in this document may
include, but is not limited to, statements with respect to:
- assumptions about the economic environment, including the
implications of inflationary pressures on customer and consumer
behaviour, supply chains, global conflicts and competitive
dynamics;
- expected future cash flows and the sufficiency thereof, sources
of capital at attractive rates, future contractual obligations,
future financing options, renewal of credit facilities, compliance
with credit facility covenants, and availability of capital to fund
growth plans, operating obligations and dividends;
- future performance, including future financial objectives,
goals and targets, category growth analysis, expected capital spend
and expected SG&A expenditures, global pork market dynamics,
Japan export market margin
outlook, labour markets, inflationary pressures (including the
ability to price for inflation);
- potential for a recurrence of a cybersecurity incident on the
Company's systems, business and operations, as well as the ability
to mitigate the financial and operational impacts, the success of
remediation and recovery efforts, the implications of data
breaches, and other ongoing risks associated with
cybersecurity;
- the execution of the Company's business strategy, including the
development and expected timing of business initiatives, brand
expansion and repositioning, plant protein category investment and
performance, market access in China and Japan, capital allocation decisions (including
investment in share repurchases under the NCIB) and investment in
potential growth opportunities and the expected returns associated
therewith;
- the impact of international trade conditions and markets on the
Company's business, including access to markets, global conflict
and other social, economic and political factors that affect
trade;
- implications associated with the spread of foreign animal
disease (such as African Swine Fever ("ASF")) and other animal
diseases such as Avian Influenza;
- competitive conditions and the Company's ability to position
itself competitively in the markets in which it competes;
- capital projects, including planning, construction, estimated
expenditures, schedules, approvals, expected capacity, in- service
dates and anticipated benefits of construction of new facilities
and expansions of existing facilities;
- the Company's dividend policy, including future levels and
sustainability of cash dividends, the tax treatment thereof and
future dividend payment dates;
- the impact of commodity prices and foreign exchange impacts on
the Company's operations and financial performance, including the
use and effectiveness of hedging instruments;
- operating risks, including the execution, monitoring and
continuous improvement of the Company's food safety programs,
animal health initiatives, cost reduction initiatives, and service
levels (including service level penalties);
- the implementation, cost and impact of environmental
sustainability initiatives, the ability of the Company to achieve
its sustainability objectives, changing climate and sustainability
laws and regulation, changes in customer and consumer expectations
related to sustainability matters, as well as the anticipated
future cost of remediating environmental liabilities;
- the adoption of new accounting standards and the impact of such
adoption on the financial position of the Company;
- expectations regarding pension plan performance, including
future pension plan assets, liabilities and contributions; and
- developments and implications of actual or potential legal
actions.
Various factors or assumptions are typically applied by the
Company in drawing conclusions or making the forecasts,
projections, predictions or estimations set out in the forward-looking statements. These factors
and assumptions are based on information
currently available to the Company, including information obtained
by the Company from third-party sources and include but are not
limited to the following:
- expectations regarding the adaptations in operations, supply
chain, customer and consumer behaviour, economic patterns
(including but not limited to global pork markets), foreign
exchange rates, international trade dynamics and access to capital,
including possible presence or absence of structural changes
associated with the economic recovery since the pandemic and global
conflicts;
- the competitive environment, associated market conditions and
market share metrics, category growth or contraction, the expected
behaviour of competitors and customers and trends in consumer
preferences;
- the success of the Company's business strategy and the
relationship between pricing, inflation, volume and sales of the
Company's products;
- prevailing commodity prices (especially in pork and feed
markets), interest rates, tax rates and exchange rates;
- potential impacts related to cybersecurity matters, including
security costs, the potential for a future incident, the risks
associated with data breaches, the availability of insurance, the
effectiveness of remediation and prevention activities, third party
activities, ongoing impacts, customer, consumer and supplier
responses and regulatory considerations;
- the economic condition of and the sociopolitical dynamics
between Canada, the U.S.,
Japan and China, and the ability of the Company to
access markets and source ingredients and other inputs in light of
global sociopolitical disruption, and the ongoing impact of global
conflicts on inflation, trade and markets;
- the spread of foreign animal disease (including ASF and Avian
Influenza), preparedness strategies to manage such spread, and
implications for all protein markets;
- the availability of and access to capital to fund future
capital requirements and ongoing operations;
- expectations regarding participation in and funding of the
Company's pension plans;
- the availability of insurance coverage to manage certain
liability exposures;
- the extent of future liabilities and recoveries related to
legal claims;
- prevailing regulatory, tax and environmental laws; and
- future operating costs and performance, including the Company's
ability to achieve operating efficiencies and maintain sales
volumes, turnover of inventories and turnover of accounts
receivable.
Readers are cautioned that these assumptions may prove to be incorrect in whole or in part.
The Company's actual results may differ materially from
those anticipated in any forward-looking statements.
Factors that could cause
actual results or outcomes to differ materially from the results
expressed, implied, or projected in the
forward-looking statements contained in this document include,
among other things, risks associated with the following:
- presence or absence of adaptations or structural changes
arising since the economic recovery following the pandemic which
may have implications for the operations and financial performance
of the Company, as well the ongoing implications for macro
socio-economic trends and global conflict;
- macro economic trends, including inflation, consumer behaviour,
recessionary indicators, labour availability and labour market
dynamics and international trade trends (including global pork
markets);
- the results of the Company's execution of its business plans,
the degree to which benefits are realized or not, and the timing
associated realizing those benefits, including the implications on
cash flow;
- competition, market conditions, and the activities of
competitors and customers, including the expansion or contraction
of key categories, inflationary pressures, pork market dynamics and
Japan export margins;
- cybersecurity and maintenance and operation of the Company's
information systems, processes and data, recovery, restoration and
long term impacts of the cybersecurity event, the risk of future
cybersecurity events, actions of third parties, risks of data
breaches, effectiveness of business continuity planning and
execution, and availability of insurance;
- the health status of livestock, including the impact of
potential pandemics;
- international trade and access to markets and supplies, as well
as social, political and economic dynamics, including global
conflicts;
- operating performance, including manufacturing operating
levels, fill rates and penalties;
- availability of and access to capital, and compliance with
credit facility covenants;
- decision respecting the return of capital to shareholders;
- the execution of capital projects and investment maintenance
capital;
- food safety, consumer liability and product recalls;
- climate change, climate regulation and the Company's
sustainability performance;
- strategic risk management;
- acquisitions and divestitures;
- fluctuations in the debt and equity markets;
- fluctuations in interest rates and currency exchange
rates;
- pension assets and liabilities;
- cyclical nature of the cost and supply of hogs and the
competitive nature of the pork market generally;
- the effectiveness of commodity and interest rate hedging
strategies;
- impact of changes in the market value of the biological assets
and hedging instruments;
- the supply management system for poultry in Canada;
- availability of plant protein ingredients;
- intellectual property, including product innovation, product
development, brand strategy and trademark protection;
- consolidation of operations and focus on protein;
- the use of contract manufacturers;
- reputation;
- weather;
- compliance with government regulation and adapting to changes
in laws;
- actual and threatened legal claims;
- consumer trends and changes in consumer tastes and buying
patterns;
- environmental regulation and potential environmental
liabilities;
- consolidation in the retail environment;
- employment matters, including complying with employment laws
across multiple jurisdictions, the potential for work stoppages due
to non-renewal of collective agreements, recruiting and retaining
qualified personnel, reliance on key personnel and succession
planning;
- pricing of products;
- managing the Company's supply chain;
- changes in International Financial Reporting Standards and
other accounting standards that the Company is required to adhere
to for regulatory purposes; and
- other factors as set out under the heading "Risk Factors" in
the Company's Management Discussion and Analysis for the year ended
December 31, 2023.
The Company cautions readers
that the foregoing list of factors
is not exhaustive.
Readers are further cautioned that some of the forward-looking
information, such as statements concerning future capital
expenditures, Adjusted EBITDA Margin expansion, and the Company's
ability to achieve its financial targets or projections may be
considered to be financial outlooks for purposes of applicable
securities legislation. These financial outlooks are presented to
evaluate potential future earnings and anticipated future uses of
cash flows and may not be appropriate for other purposes. Readers
should not assume these financial outlooks will be achieved.
More information about risk factors can be found under the
heading "Risk Factors" in the Company's Annual Management's
Discussion and Analysis for the year ended December 31, 2023, that is available on SEDAR+ at
www.sedarplus.ca. The reader should review such section in detail.
Additional information concerning the Company, including the
Company's Annual Information Form, is available on SEDAR+ at
www.sedarplus.ca.
All forward-looking statements included herein speak only as of
the date hereof. Unless required by law, the Company does not
undertake any obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. All forward-looking statements
contained herein are expressly qualified by this cautionary
statement.
About Maple Leaf Foods Inc.
Maple Leaf Foods is a carbon
neutral(i) company with a vision to be the
most sustainable protein company on earth, responsibly producing
food products under leading brands including Maple Leaf®, Maple
Leaf Prime®, Maple Leaf Natural Selections®, Schneiders®,
Schneiders® Country Naturals®, Mina®, Greenfield Natural Meat Co.®,
Lightlife® and Field Roast™. The Company employs approximately
13,500 people and does business primarily in Canada, the U.S. and Asia. The
Company is headquartered in Mississauga,
Ontario and its shares trade on the Toronto Stock Exchange
(MFI).
(i)
|
See the Company's
2023 Integrated Report that is available on the Maple Leaf Foods
website at
https://www.mapleleaffoods.com/wp-content/uploads/sites/6/2024/04/MLF_2023_Integrated-Report.pdf
|
Consolidated Interim Balance Sheets
(In thousands
of Canadian dollars)
|
As at March 31,
|
As at March
31,
|
As at December 31,
|
(Unaudited)
2024
|
2023
|
2023
|
ASSETS
|
|
|
|
Cash and cash equivalents
|
$
206,393
|
$
79,433
|
$
203,363
|
Accounts
receivable
|
168,994
|
160,290
|
183,798
|
Notes
receivable
|
32,564
|
35,506
|
33,220
|
Inventories
|
584,134
|
576,183
|
542,392
|
Biological assets
|
180,281
|
140,100
|
114,917
|
Income
taxes recoverable
|
83,365
|
66,977
|
88,896
|
Prepaid
expenses and other assets
|
43,620
|
47,004
|
44,865
|
Assets
held for sale
|
—
|
11,204
|
—
|
Total current assets
|
$
1,299,351
|
$ 1,116,697
|
$ 1,211,451
|
Property
and equipment
|
2,224,502
|
2,297,130
|
2,251,710
|
Right-of-use assets
|
169,145
|
155,140
|
154,610
|
Investments
|
16,029
|
23,656
|
15,749
|
Investment property
|
57,144
|
5,289
|
57,144
|
Employee
benefits
|
32,557
|
16,599
|
26,785
|
Other long-term assets
|
22,303
|
9,223
|
22,336
|
Deferred
tax asset
|
41,980
|
42,525
|
40,854
|
Goodwill
|
477,353
|
477,353
|
477,353
|
Intangible assets
|
344,938
|
356,297
|
345,129
|
Total long-term assets
|
$
3,385,951
|
$ 3,383,212
|
$ 3,391,670
|
Total assets
|
$
4,685,302
|
$ 4,499,909
|
$ 4,603,121
|
LIABILITIES AND
EQUITY
|
|
|
|
Accounts payable and accruals
|
$
590,696
|
$ 605,777
|
$
548,444
|
Current
portion of provisions
|
6,586
|
36,114
|
9,846
|
Current
portion of long-term debt
|
401,538
|
1,130
|
400,735
|
Current
portion of lease obligations
|
39,928
|
37,349
|
38,031
|
Income
taxes payable
|
1,788
|
1,100
|
2,382
|
Other
current liabilities
|
25,518
|
42,533
|
32,974
|
Total current liabilities
|
$
1,066,054
|
$ 724,003
|
$ 1,032,412
|
Long-term debt
|
1,527,665
|
1,755,560
|
1,550,080
|
Lease
obligations
|
154,863
|
140,304
|
142,286
|
Employee
benefits
|
62,230
|
65,966
|
64,196
|
Provisions
|
2,037
|
3,631
|
2,041
|
Other long-term liabilities
|
1,202
|
2,197
|
1,124
|
Deferred
tax liability
|
317,978
|
218,903
|
296,203
|
Total long-term liabilities
|
$
2,065,975
|
$ 2,186,561
|
$ 2,055,930
|
Total liabilities
|
$
3,132,029
|
$ 2,910,564
|
$ 3,088,342
|
Shareholders' equity
|
|
|
|
Share
capital
|
$
878,852
|
$ 850,616
|
$
873,477
|
Retained
earnings
|
628,549
|
728,477
|
597,429
|
Contributed surplus
|
7,750
|
3,047
|
3,227
|
Accumulated other comprehensive income
|
45,305
|
33,121
|
47,829
|
Treasury
shares
|
(7,183)
|
(25,916)
|
(7,183)
|
Total shareholders' equity
|
$
1,553,273
|
$ 1,589,345
|
$ 1,514,779
|
Total liabilities and equity
|
$
4,685,302
|
$ 4,499,909
|
$ 4,603,121
|
Consolidated Interim Statements of Net Earnings
(Loss)
|
Three months ended
March 31,
|
(In thousands of Canadian dollars, except share amounts)
(Unaudited)
|
2024
|
2023(i)
|
Sales
|
$
1,153,225
|
$
1,171,067
|
Cost of goods
sold
|
926,885
|
1,094,620
|
Gross profit
|
$ 226,340
|
$
76,447
|
Selling, general and
administrative expenses
|
110,033
|
102,713
|
Earnings
(loss) before the following:
|
$ 116,307
|
$ (26,266)
|
Restructuring and other
related (reversals) costs
|
(725)
|
7,749
|
Other expense
|
1,157
|
4,295
|
Earnings
(loss) before interest and income taxes
|
$ 115,875
|
$ (38,310)
|
Interest expense and other financing costs
|
42,083
|
31,603
|
Earnings
(loss) before income taxes
|
$
73,792
|
$ (69,913)
|
Income tax expense (recovery)
|
22,241
|
(12,209)
|
Net earnings (loss)
|
$
51,551
|
$ (57,704)
|
Earnings (loss) per
share attributable to common shareholders:
|
|
|
Basic earnings (loss)
per share
|
$
0.42
|
$
(0.48)
|
Diluted earnings (loss)
per share
|
$
0.42
|
$
(0.48)
|
Weighted average number of shares
(millions):
|
|
|
Basic
|
122.5
|
121.3
|
Diluted
|
123.6
|
121.3
|
(i)
|
Quarterly amounts
for 2023 have been adjusted see Note 17 in the condensed
consolidated interim financial statements.
|
Consolidated Interim Statements of Other Comprehensive Income
(Loss)
(In thousands of Canadian dollars)
|
|
Three months ended March 31,
|
(Unaudited)
|
2024
|
2022
|
Net earnings (loss)
|
$
51,551
|
$ (57,704)
|
Other comprehensive
income
|
|
|
Actuarial (losses)
gains that will not be reclassified to profit or loss
(Net of tax of $2.2 million; 2023: $0.7 million)
|
$
6,605
|
$
2,124
|
Change in revaluation
surplus (Net of tax of $0.0 million; 2023:$1.7 million)
|
—
|
6,993
|
Total items that will
not be reclassified to profit or loss
|
$
6,605
|
$
9,117
|
Items that are or may
be reclassified subsequently to profit or loss:
|
|
|
Change
in accumulated foreign currency translation adjustment
(Net of tax of $0.0
million; 2023: $0.0 million)
|
7,710
|
(433)
|
Change
in foreign exchange on long-term debt designated as a net
investment hedge
(Net of tax of $1.2 million; 2023: $0.0
million)
|
(6,612)
|
119
|
Change in cash flow
hedges (Net of tax of $0.2 million; 2023: $1.1 million)
|
(3,622)
|
(3,105)
|
Total items that are
or may be reclassified subsequently to profit or loss
|
$
(2,524)
|
$
(3,419)
|
Total other
comprehensive income
|
$
4,081
|
$
5,698
|
Comprehensive income
(loss)
|
$
55,632
|
$
(52,006)
|
Consolidated Statements of Changes in Total Equity
|
|
|
|
Accumulated other
comprehensive
income (loss)
|
|
|
(in thousands of
Canadian dollars)
|
Share
capital
|
Retained
earnings
|
Contributed
surplus
|
Foreign
currency
translation
adjustment(i)
|
Unrealized
gains and
losses on
cash flow
hedges(i)
|
Unrealized
gains on fair
value of
investments (i)
|
Revaluation
surplus
|
Treasury
stock
|
Total
equity
|
Balance at December 31, 2023
|
$873,477
|
597,429
|
3,227
|
8,625
|
4,416
|
(2,559)
|
37,347
|
(7,183)
|
$ 1,514,779
|
Net earnings
|
—
|
51,551
|
—
|
—
|
—
|
—
|
—
|
—
|
51,551
|
Other comprehensive income
|
|
|
|
|
|
|
(loss)(ii)
|
—
|
6,605
|
—
|
1,098
|
(3,622)
|
—
|
—
|
—
|
4,081
|
Dividends declared ($0.22 per
share)
|
5,375
|
(27,036)
|
—
|
—
|
—
|
—
|
—
|
—
|
(21,661)
|
Share-based compensation
expense
|
—
|
—
|
5,298
|
—
|
—
|
—
|
—
|
—
|
5,298
|
Deferred taxes on
share-
based compensation
|
—
|
—
|
(775)
|
—
|
—
|
—
|
—
|
—
|
(775)
|
Balance at March
31, 2024
|
$878,852
|
628,549
|
7,750
|
9,723
|
794
|
(2,559)
|
37,347
|
(7,183)
|
$
1,553,273
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated other
comprehensive income (loss)
|
|
|
(In thousands of Canadian dollars)
|
Share
capital
|
Retained
earnings
|
Contributed
surplus
|
Foreign
currency translation
adjustment
|
Unrealized
gains and
losses on
cash flow
hedges
|
Unrealized
gains on fair
value of
investments
|
Revaluation
surplus
|
Treasury
stock
|
Total
equity
|
Balance at December 31, 2022
|
$850,086
|
809,616
|
—
|
10,972
|
12,885
|
2,945
|
$
2,745
|
(25,916) $
|
1,663,333
|
Net loss
|
—
|
(57,704)
|
—
|
—
|
—
|
—
|
—
|
—
|
(57,704)
|
Other comprehensive income
|
|
|
|
|
|
|
|
(loss)(ii)
|
—
|
2,124
|
—
|
(314)
|
(3,105)
|
—
|
6,993
|
—
|
5,698
|
Dividends declared ($0.21 per
share)
|
—
|
(25,559)
|
—
|
—
|
—
|
—
|
—
|
—
|
(25,559)
|
Share-based
compensation
expense
|
—
|
—
|
2,012
|
—
|
—
|
—
|
—
|
—
|
2,012
|
Deferred taxes
on share-based
compensation
|
—
|
—
|
800
|
—
|
—
|
—
|
—
|
—
|
800
|
Exercise of stock
options
|
769
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
769
|
Shares
re-purchased
|
(2,931)
|
—
|
(7,838)
|
—
|
—
|
—
|
—
|
—
|
(10,769)
|
Change in obligation
for
repurchase of
shares
|
2,692
|
—
|
8,073
|
—
|
—
|
—
|
—
|
—
|
10,765
|
Balance at March 31, 2023
|
$850,616
|
728,477
|
3,047
|
10,658
|
9,780
|
2,945
|
9,738
|
(25,916)
|
$ 1,589,345
|
(i)
|
Items that are or may be subsequently reclassified to profit or
loss.
|
(ii)
|
Included in other comprehensive income (loss) is the
change in actuarial gains and losses that will not be reclassified
to profit or loss and has been reclassified to retained
earnings.
|
Consolidated Interim
Statements of Cash Flows
(In thousands of Canadian dollars)
Three months ended March 31,
|
(Unaudited)
|
2024
|
2023
|
CASH PROVIDED BY (USED IN):
Operating activities
Net earnings (loss)
|
$
51,551
|
$ (57,704)
|
Add (deduct) items
not affecting cash:
Change in fair
value of biological assets
|
(69,143)
|
1,127
|
Depreciation and amortization
|
65,853
|
67,425
|
Share-based compensation
|
5,298
|
2,012
|
Deferred
income tax (recovery) expense
|
19,936
|
(2,874)
|
Current
income tax (recovery) expense
|
2,305
|
(9,335)
|
Interest
expense and other financing costs
|
42,083
|
31,603
|
(Gain)
loss on sale of long-term assets
|
(311)
|
234
|
Change
in fair value
of non-designated derivatives
|
(4,665)
|
3,109
|
Change in net
pension obligation
|
1,067
|
467
|
Net income taxes
refunded (paid)
|
2,982
|
(1,777)
|
Interest
paid, net of capitalized interest
Change in provision for restructuring and
other related costs
Change
in derivatives margin
|
(40,477)
(3,260)
2,316
|
(33,790)
(6,006)
(13,740)
|
Cash settlement of derivatives
|
(2,150)
|
11,009
|
Other
|
3,093
|
217
|
Change
in non-cash operating working capital
|
10,847
|
43,737
|
Cash provided by operating activities
|
$
87,325
|
$
35,714
|
Investing activities
Additions to long-term assets
|
$
(23,813)
|
$ (49,252)
|
Interest
paid and capitalized
|
(355)
|
(481)
|
Proceeds
from sale of long-term assets
|
865
|
64
|
Cash used in investing activities
|
$
(23,303)
|
$ (49,669)
|
Financing activities
Dividends paid
|
$
(21,661)
|
$ (25,559)
|
Net (decrease) increase in long-term debt
|
(30,885)
|
48,800
|
Payment
of lease obligation
|
(8,446)
|
(9,918)
|
Exercise
of stock options
|
—
|
769
|
Repurchase of shares
|
—
|
(10,769)
|
Payment
of financing fees
|
—
|
(1,011)
|
Cash (used in) provided
by financing activities
|
$
(60,992)
|
$
2,312
|
Increase (decrease) in cash and
cash equivalents
|
$
3,030
|
$ (11,643)
|
Cash and cash
equivalents, beginning of period
|
203,363
|
91,076
|
Cash and cash
equivalents, end of period
|
$ 206,393
|
$
79,433
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/maple-leaf-foods-reports-first-quarter-2024-financial-results-302134314.html
SOURCE Maple Leaf Foods Inc.